Don’t miss Eli Lilly’s presentation on metrics and data usage to assess protocol-level risk before, during and after a study. This WebEx will be led by Nancy Dynes, Consultant, Global Medical Quality Metrics at Eli Lilly, and discussion topics will include:
• RBM data perspective
• How to use data to prepare for RBM in a trial
• How to use data to monitor the RBM process across trials
Presentation date and time: Thursday, March 12th, at 11 a.m. EST
*Please note: this presentation will not be recorded.
This presentation is open to members only.